Fig. 1. VHL−/− ccRCC cells exhibit altered H3K27 modifications and increased dependence on EZH1. VHL−/− ccRCC cells exhibit altered H3K27 modifications.

Slides:



Advertisements
Similar presentations
Myc‐induced miRNAs attenuate differentiation of c‐Myc‐depleted ES cells on LIF withdrawal. Myc‐induced miRNAs attenuate differentiation of c‐Myc‐depleted.
Advertisements

IRES‐dependent translation is specifically abolished by an IRES point mutation. IRES‐dependent translation is specifically abolished by an IRES point mutation.
Fig. 8. Recurrent copy number amplification of BRD4 gene was observed across common cancers. Recurrent copy number amplification of BRD4 gene was observed.
Volume 16, Issue 5, Pages (November 2009)
Fig. 4. Primary human metastatic melanomas contain CCL21-expressing LECs, and expression of VEGFC positively correlates with hallmarks of tumor inflammation.
Fig. 1. Generation of ERY974. Generation of ERY974. (A) Schematic illustration of ERY974 structure and the introduced mutations. The two Fab arms share.
Fig. 6. AZD6738 induces DNA damage and apoptosis and exhibits antitumor efficacy in xenograft models of high-risk medulloblastoma and neuroblastoma. AZD6738.
Fig. 3. Copy number loss as a potential resistance mechanism in an independent cohort. Copy number loss as a potential resistance mechanism in an independent.
Volume 21, Issue 9, Pages (November 2017)
Volume 54, Issue 4, Pages (October 2008)
Fig. 6. dAST directly from clinical samples using dPCR and dLAMP for quantification. dAST directly from clinical samples using dPCR and dLAMP for quantification.
Fig. 5. Blocking LTB4 during initial lymphangiogenesis period abrogates the therapeutic benefit of LTB4 antagonism. Blocking LTB4 during initial lymphangiogenesis.
SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer
Fig. 1. The cell-intrinsic fibroblast circadian proteome contains numerous cytoskeletal regulators. The cell-intrinsic fibroblast circadian proteome contains.
EP4 promoter activity is induced by sulindac sulfide in T98G cells.
Transfer of miR-223 during neutrophil-epithelial cell interactions
Fig. 5. Circulating PPi concentration does not correlate with severity of calcification phenotype in mice. Circulating PPi concentration does not correlate.
Volume 11, Issue 5, Pages (May 2007)
Fig. 4. Intramuscular injection of AAV9-Cas9/sgRNA-51 corrects dystrophin expression. Intramuscular injection of AAV9-Cas9/sgRNA-51 corrects dystrophin.
Fig. 4 Bacterial taxonomic groups that discriminate among RYGB-, SHAM-, and WMS-derived samples. Bacterial taxonomic groups that discriminate among RYGB-,
β-ARs signal cooperatively with mutant EGFR and inactivate LKB1
Fig. 4. Liver HBV mRNA paired-end sequencing reads in HBeAg-positive and HBeAg-negative chimpanzees. Liver HBV mRNA paired-end sequencing reads in HBeAg-positive.
Fig. 3. LTB4 exhibits concentration-dependent effects on HLEC lymphangiogenesis and survival. LTB4 exhibits concentration-dependent effects on HLEC lymphangiogenesis.
Fig. 1. Schematic representation of the MANO method.
JQ1 directly represses the promoter activities of BRCA1 and RAD51
Fig. 2 TLR8 is aberrantly expressed on pDCs from SSc patients.
Fig. 3. Frequencies of amino acids at critical PGT121 and contact sites in the SHIV-SF162P3 challenge stock. Frequencies of amino acids at critical.
Fig. 6. Pathway analysis of CMLD
Fig. 3. A circadian rhythm in fibroblast wound-healing response.
Volume 9, Issue 2, Pages (February 2011)
Fig. 2. GPC3 expression in normal and tumor tissues.
Fig. 5. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic mice. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic.
Fig. 6. PVSRIPO oncolysate–pulsed DCs generate tumor antigen–specific CTL immunity in vitro. PVSRIPO oncolysate–pulsed DCs generate tumor antigen–specific.
Fig. 5 A competent Fc is required for the antitumor immune response.
Identification of TLOC1 and SKIL as tumor driver genes in 3q26.
Fig. 4. Antitumor efficacy of ERY974 against various cancer types.
Fig. 5. In vivo characterization of adipogenesis by CT.
Fig. 6. A circadian rhythm in keratinocyte wound healing and a diurnal variation in human burn healing outcome. A circadian rhythm in keratinocyte wound.
Fig. 7 pDCs are critical for the maintenance of skin fibrosis and for the presence of CXCL4 in the skin. pDCs are critical for the maintenance of skin.
Fig. 6 pDCs infiltrate the skin of BLM-treated mice, and their depletion attenuates skin fibrosis. pDCs infiltrate the skin of BLM-treated mice, and their.
Fig. 4. Actin polymerization rhythms are required for circadian regulation of adhesion and wound-healing efficacy by fibroblasts. Actin polymerization.
Fig. 1. Experimental workflow of the dAST method and computationally estimated operational space. Experimental workflow of the dAST method and computationally.
Fig. 3. AD80 is active against gatekeeper mutant RETV804M cells.
Fig. 6. FGFR1 and CCND1 amplification–mediated resistance to estrogen deprivation is therapeutically actionable. FGFR1 and CCND1 amplification–mediated.
Antiproliferative effects of JQ-EZ-05 on VHL−/− ccRCC are on-target
Fig. 1. mGlu7 expression is reduced in RTT autopsy samples.
Workflow of a sample-to-answer AST performed in less than 30 min
Fig. 1. Drug combination screen identifies BETi as acting synergistically with PARPi. Drug combination screen identifies BETi as acting synergistically.
Fig. 5 Local gel scaffold for T cell memory response.
Fig. 2 Fas controls IL-1RA–sEV secretion in murine MSCs.
HECTD2 knockdown ameliorates Pseudomonas-induced lung injury in vivo
A genome-wide RNAi pooled screen identifies NF1 as a key determinant of RAF inhibitor sensitivity in melanoma cells. A genome-wide RNAi pooled screen identifies.
Fig. 2 Analysis of CLL lymph nodes.
Induction of LIMD1 in hypoxia inhibits HIF‐1‐mediated gene expression
Fig. 1. Bexarotene promotes PPARδ activation to ameliorate the neurotoxicity of mutant huntingtin. Bexarotene promotes PPARδ activation to ameliorate the.
Fig. 6. Analysis of SHIV-325c V1V2 envelope sequences in breakthrough infections. Analysis of SHIV-325c V1V2 envelope sequences in breakthrough infections.
Fig. 3 Agonists of innate immunity are effective only when released locally from the hydrogel. Agonists of innate immunity are effective only when released.
Fig. 3 CSF1 is expressed in human melanoma.
TYK2 is required for the survival of T-ALL cells.
Fig. 5 Early and modest immune response at day 3 after exposure in Delayed animals. Early and modest immune response at day 3 after exposure in Delayed.
Correlation of reovirus RNA/protein with proliferating tumor cells
Fig. 4 ALRN-6924 inhibits cellular proliferation and clonogenic capacity, and induces cell cycle arrest and apoptosis in AML cell lines. ALRN-6924 inhibits.
AML cells display differential sensitivity to inhibition of IKBKE and TBK1. AML cells display differential sensitivity to inhibition of IKBKE and TBK1.
eIF5A-PEAK1 signaling regulates KRAS protein expression.
Deubiquitinating activity, but not HCF-1 binding, is required for BAP1 function in thymocytes. Deubiquitinating activity, but not HCF-1 binding, is required.
Fig. 2. Clinically actionable somatic genomic alterations in various tumor types. Clinically actionable somatic genomic alterations in various tumor types.
Fig. 5 A competent Fc is required for the antitumor immune response.
by Jianping Guo, Abhishek A
The prostate cancer risk variant rs regulates multiple gene expression through extreme long-range chromatin interaction to control tumor progression.
Fig. 2 Astrocyte-specific AAV2/5 RiboTag.
Presentation transcript:

Fig. 1. VHL−/− ccRCC cells exhibit altered H3K27 modifications and increased dependence on EZH1. VHL−/− ccRCC cells exhibit altered H3K27 modifications and increased dependence on EZH1. (A) Quantification of the indicated histone modifications, as measured by mass spectrometry analysis (described in fig. S1), in renal tumor samples annotated as ccRCCs, typical pRCCs (type 1), atypical pRCCs, and chRCCs. P values were calculated using Student’s t test, and P < 0.05 was considered significant. NS, not significant. (B) Short hairpin RNA (shRNA) screen schema. (C) Genes whose shRNAs exhibited the greatest depletion or enrichment in the VHL−/− ccRCC relative to isogenic pVHL-proficient cells, as determined by RIGER. (D) Immunoblots of UMRC-2 cells that were lentivirally infected to produce pVHL and then stably infected to produce the indicated EZH1 shRNAs or an shRNA against firefly luciferase (Luc). The shRNAs in the screen are indicated in red. (E) Crystal violet staining of UMRC-2 that were lentivirally infected to produce pVHL (VHL) or infected with an empty lentivirus (VEC) and then stably infected to produce the indicated EZH1 shRNAs or an shRNA against firefly luciferase (Luc). (F) Photomicrographs of CAKI-2 cells that were infected to produce exogenous wild-type (WT) EZH1, catalytic-dead EZH1 (ΔSET), or with the empty vector (VEC) and then with a lentivirus encoding an EZH1 shRNA (10708) or control shRNA. The EZH1 WT vector contained synonymous mutations in the sequence recognized by the 10708 shRNA. The ΔSET mutation also eliminates the 10708 recognition sequence. Abhishek A. Chakraborty et al., Sci Transl Med 2017;9:eaal5272 Published by AAAS